BFX

4-{4-[3-(2-bromo-5-fluorophenoxy)propyl]phenyl}-N-(2-chlorobenzyl)-N-cyclopropyl-1,2,5,6-tetrahydropyridine-3-carboxamide

Created:	2009-10-08
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where BFX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	69
Chiral Atom Count	0
Bond Count	73
Aromatic Bond Count	18

2D diagram of BFX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-{4-[3-(2-bromo-5-fluorophenoxy)propyl]phenyl}-N-(2-chlorobenzyl)-N-cyclopropyl-1,2,5,6-tetrahydropyridine-3-carboxamide
Systematic Name (OpenEye OEToolkits)	4-[4-[3-(2-bromo-5-fluoro-phenoxy)propyl]phenyl]-N-[(2-chlorophenyl)methyl]-N-cyclopropyl-1,2,3,6-tetrahydropyridine-5-carboxamide
Formula	C₃₁ H₃₁ Br Cl F N₂ O₂
Molecular Weight	597.945
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	11.02	Clc1ccccc1CN(C(=O)C4=C(c2ccc(cc2)CCCOc3cc(F)ccc3Br)CCNC4)C5CC5
SMILES	CACTVS	3.352	Fc1ccc(Br)c(OCCCc2ccc(cc2)C3=C(CNCC3)C(=O)N(Cc4ccccc4Cl)C5CC5)c1
SMILES	OpenEye OEToolkits	1.7.0	c1ccc(c(c1)CN(C2CC2)C(=O)C3=C(CCNC3)c4ccc(cc4)CCCOc5cc(ccc5Br)F)Cl
Canonical SMILES	CACTVS	3.352	Fc1ccc(Br)c(OCCCc2ccc(cc2)C3=C(CNCC3)C(=O)N(Cc4ccccc4Cl)C5CC5)c1
Canonical SMILES	OpenEye OEToolkits	1.7.0	c1ccc(c(c1)CN(C2CC2)C(=O)C3=C(CCNC3)c4ccc(cc4)CCCOc5cc(ccc5Br)F)Cl
InChI	InChI	1.03	InChI=1S/C31H31BrClFN2O2/c32-28-14-11-24(34)18-30(28)38-17-3-4-21-7-9-22(10-8-21)26-15-16-35-19-27(26)31(37)36(25-12-13-25)20-23-5-1-2-6-29(23)33/h1-2,5-11,14,18,25,35H,3-4,12-13,15-17,19-20H2
InChIKey	InChI	1.03	GNQKDXQPKKYVIX-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	10348528
ChEMBL	CHEMBL1088430

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.